Creative Operating Margin from 2010 to 2026
| CELZ Stock | USD 1.86 0.03 1.64% |
Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.9 M, Other Operating Expenses of 6.9 M or Total Operating Expenses of 6.9 M, as well as many indicators such as Price To Sales Ratio of 159, Dividend Yield of 0.0 or PTB Ratio of 0.65. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.
Creative | Operating Margin | Build AI portfolio with Creative Stock |
The evolution of Operating Margin for Creative Medical Technology provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Creative Medical compares to historical norms and industry peers.
Latest Creative Medical's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Creative Medical Technology over the last few years. It is Creative Medical's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Creative Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.00 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Creative Operating Margin Regression Statistics
| Arithmetic Mean | (262.02) | |
| Coefficient Of Variation | (78.56) | |
| Mean Deviation | 149.35 | |
| Median | (245.38) | |
| Standard Deviation | 205.85 | |
| Sample Variance | 42,372 | |
| Range | 618 | |
| R-Value | (0.41) | |
| Mean Square Error | 37,689 | |
| R-Squared | 0.17 | |
| Significance | 0.10 | |
| Slope | (16.61) | |
| Total Sum of Squares | 677,959 |
Creative Operating Margin History
About Creative Medical Financial Statements
Creative Medical investors use historical fundamental indicators, such as Creative Medical's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. Creative Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.